These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17443463)

  • 21. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.
    Hitchcock WP
    Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whooping cough immunity.
    Thomas MG
    N Z Med J; 1989 Jan; 102(860):22. PubMed ID: 2536476
    [No Abstract]   [Full Text] [Related]  

  • 23. Arm your patients against whooping cough.
    Heavey E
    Nursing; 2008 Feb; 38(2):22-3. PubMed ID: 18223407
    [No Abstract]   [Full Text] [Related]  

  • 24. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of pertussis among children in Eastern Turkey.
    Inandi T; Guraksin A; Hacialioglu N
    Public Health; 2005 Jun; 119(6):550-5. PubMed ID: 15826897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bordetella pertussis in the National Capital Region: prevalent serotype and immunization status of patients.
    Rossier E; Chan F
    Can Med Assoc J; 1977 Nov; 117(10):1169-71. PubMed ID: 203375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staying ahead of pertussis.
    Rivard G; Viera A
    J Fam Pract; 2014 Nov; 63(11):658-69. PubMed ID: 25362496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indices of the strength of collective pertussis immunity].
    Ryzhenko IM; Verezub LG; Vil'vovskaia RI; Tigraniants VN; Dubova ON
    Vrach Delo; 1981 Jul; (7):111-4. PubMed ID: 6269302
    [No Abstract]   [Full Text] [Related]  

  • 31. Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany demonstrating the role of waning immunity.
    Sin MA; Zenke R; Rönckendorf R; Littmann M; Jorgensen P; Hellenbrand W
    Pediatr Infect Dis J; 2009 Mar; 28(3):242-4. PubMed ID: 19209094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.
    Bancroft T; Dillon MB; da Silva Antunes R; Paul S; Peters B; Crotty S; Lindestam Arlehamn CS; Sette A
    Cell Immunol; 2016; 304-305():35-43. PubMed ID: 27212461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Seroepidemiological studies on the immunization of the population against species of the genus Bordetella in 1996-1997].
    Mihai G; Alecu V; Neagu A
    Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):157-60. PubMed ID: 9932004
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunizations. New recommendations for children's vaccines: one against meningitis..Tdap [corrected] "booster" for 11-12 year olds...but not a booster for chicken pox.
    Child Health Alert; 2005 Sep; 24():2-3. PubMed ID: 16237805
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistent pertussis.
    Ortolon K
    Tex Med; 2002 Jun; 98(6):38-42. PubMed ID: 12073900
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal Timing of Immunization Against Pertussis During Pregnancy.
    Abu Raya B; Srugo I; Bamberger E
    Clin Infect Dis; 2016 Jul; 63(1):143-4. PubMed ID: 27090990
    [No Abstract]   [Full Text] [Related]  

  • 37. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis update: focus on adolescents.
    Bartell JC; Hayney MS
    J Am Pharm Assoc (2003); 2005; 45(6):762-4. PubMed ID: 16381425
    [No Abstract]   [Full Text] [Related]  

  • 40. Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?
    Birkebaek NH
    Clin Infect Dis; 2009 Aug; 49(4):588-90. PubMed ID: 19589080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.